SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIbstock Regulatory News (IBST)

Share Price Information for Ibstock (IBST)

Share Price is delayed by 15 minutes
Get Live Data
95.00    3.15 (3.43%)
Bid:
95.05
Ask:
95.60
Spread: 0.55 (0.579%)
Market Cap: £375.27m
IBST Live PriceLast checked at - London Stock Exchange

Intraday Ibstock Share Chart

Director/PDMR Shareholding

13 Aug 2019 15:52

RNS Number : 9124I
Ibstock PLC
13 August 2019
 

13 August 2019

 

Ibstock plc (the "Company")

 

Grant of Awards under the Ibstock plc Long Term Incentive Plan and the Buy-out Agreement

 

Notification of Transactions by Persons Discharging Managerial Responsibility ("PDMRs")

 

The Company announces that it granted an award ("LTIP Award") over Ibstock plc ordinary shares of 1 penny each ("Ordinary Shares") on 12 August 2019 to a PDMR in accordance with the rules of the Ibstock plc Long Term Incentive Plan.

 

Name

Status

Number of Ordinary Shares under LTIP Award

Option Price

Chris McLeish

Chief Financial Officer Designate

170,145

£Nil

 

No consideration was paid for the grant of the LTIP Award which is structured as a nil cost option. The number of Ordinary Shares granted under the LTIP Award has been calculated using an Ordinary Share price of 220.4 pence per share.

 

The normal vesting date of the LTIP Award will be 12 August 2022, being the third anniversary of the award date.

 

Once vested, the LTIP Award will normally be exercisable until the day before the tenth anniversary of the award date.

 

The LTIP Award will normally vest after three years based on the satisfaction of the following performance conditions:-

 

i. 50% on relative TSR against the FTSE 250 construction and building materials companies: median performance (threshold); upper quartile performance (maximum); and

ii. 50% on compound annual Adjusted EPS growth: 6% p.a. compound growth (threshold); 12% p.a. compound growth (maximum).

 

25% of the LTIP Award will vest for threshold performance under both measures, with straight line vesting in between to full vesting for the achievement of maximum performance.

 

A holding period applies, which will commence on vesting of the LTIP Award and end 2 years after vesting.

 

On 12 August 2019 the Company also granted an award ("Buy-out Award") over Ordinary Shares in accordance with the terms of a Buy-out Agreement.

 

Name

Status

Number of Ordinary Shares under Buy-out Award

Option Price

Chris McLeish

Chief Financial Officer Designate

60,393

£Nil

 

The Board agreed to grant the Buy-out Award to compensate, on a fair value basis, the value forgone by Chris McLeish for share awards forfeited on cessation of employment with his previous employer (Tate & Lyle). Mr McLeish's Buy-out Award replaces his awards over Tate & Lyle plc shares for both 2017 and 2018 forfeited as a result of his resignation from Tate & Lyle plc. The fair value of the Buy-out Award has been reduced to take account of the original performance period and the proportion of satisfaction of the performance conditions as at the time of the buy-out. The vesting level will be revisited at the time of vesting to adjust the number of Ibstock shares which vest to reflect the actual vesting of the original Tate & Lyle awards.

 

No consideration was paid for the grant of the Buy-out Award which is structured as a nil cost option. The number of Ordinary Shares granted under the Buy-out Award has been calculated in accordance with the terms of the Buy-out Agreement, based on the value of 18,533 Tate & Lyle shares determined using the Tate & Lyle average closing share price of 754.7 pence measured over the three days prior to 1 August 2019 converted to Ibstock shares using Ibstock's average closing share price of 231.6 pence measured over the three days prior to 1 August 2019, being the date when Chris McLeish commenced employment with Ibstock.

 

The Buy-out Award will normally vest in two instalments on 31 March 2020 and 31 March 2021, in line with the vesting schedule of the original Tate & Lyle plc awards. Once vested, the Buy-out Award will normally be exercisable until the day before the tenth anniversary of the original award dates (1 April 2027 and 1 April 2028 respectively).

 

The level of vesting of the Buy-out Award will be adjusted upwards or downwards as determined by the Remuneration Committee (including, for the avoidance of doubt, to nil) to reflect performance against the targets attached to the original awards.

 

The information below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Chris McLeish

2

 

Reason for the notification

a)

Position/status

Chief Financial Officer Designate

b)

Initial notification/Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Ibstock plc

b)

LEI

2138003QHTNX34CN9V93

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Ordinary shares of 1p each

Identification code

GB00BYXJC278

b)

 

Nature of the transaction

Grant of awards under (a) the Ibstock plc Long Term Incentive Plan and (b) the Buy-out Agreement

c)

 

Price(s) and volume(s)

Price(s)

Volume(s)

(a)

Nil

170,145

(b)

Nil

60,393

d)

 

Aggregated information

- Aggregated volume

230,538

- Price

Nil

e)

Date of the transaction

2019-08-12

f)

Place of the transaction

Outside a trading venue

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHDMGMRDFLGLZM
Date   Source Headline
22nd May 20269:00 amRNSHolding(s) in Company
21st May 20261:51 pmRNSResult of AGM
21st May 20267:00 amRNSAGM Trading Update
14th May 202611:00 amRNSHolding(s) in Company
13th May 20263:55 pmRNSHolding(s) in Company
13th May 20263:39 pmRNSHolding(s) in Company
1st May 20268:26 amRNSTotal Voting Rights
29th Apr 20264:11 pmRNSHolding(s) in Company
21st Apr 20262:38 pmRNSDirector/PDMR Shareholding
21st Apr 20267:03 amRNSAppointment of Chief Financial Officer
17th Apr 202611:00 amRNSDirector/PDMR Shareholding
10th Apr 20263:00 pmRNSDirector/PDMR Shareholding
1st Apr 20269:04 amRNSTotal Voting Rights
25th Mar 20269:16 amRNSNotice of AGM
24th Mar 20262:17 pmRNSHolding(s) in Company
17th Mar 20264:00 pmRNSDirector/PDMR Shareholding
11th Mar 20263:15 pmRNSHolding(s) in Company
6th Mar 20263:00 pmRNSHolding(s) in Company
5th Mar 20267:01 amRNSAppointment of Non-Executive Director
5th Mar 20267:00 amRNSResults for the year ended 31 December 2025
2nd Mar 202610:02 amRNSTotal Voting Rights
25th Feb 202610:00 amRNSHolding(s) in Company
2nd Feb 20264:21 pmRNSTotal Voting Rights
22nd Jan 20268:55 amRNSHolding(s) in Company
20th Jan 20267:00 amRNSTrading Statement
12th Jan 20262:51 pmRNSHolding(s) in Company
2nd Jan 202610:00 amRNSBlock listing Six Monthly Return
11th Dec 20253:00 pmRNSHolding(s) in Company
13th Nov 20252:00 pmRNSRefinancing of £125m revolving credit facility
10th Oct 20257:00 amRNSThird Quarter Trading Update
2nd Oct 202510:00 amRNSDirectorate Change
1st Oct 20258:04 amRNSTotal Voting Rights
26th Sep 20252:30 pmRNSHolding(s) in Company
16th Sep 20252:00 pmRNSDirector/PDMR Shareholding
29th Aug 20253:30 pmRNSHolding(s) in Company
29th Aug 202510:00 amRNSHolding(s) in Company
22nd Aug 202512:21 pmRNSHolding(s) in Company
6th Aug 20257:00 amRNSInterim Results
30th Jul 20252:00 pmRNSHolding(s) in Company
18th Jul 202511:00 amRNSHolding(s) in Company
15th Jul 20257:00 amRNSNotice of Results
10th Jul 20259:30 amRNSHolding(s) in Company
4th Jul 20259:30 amRNSHolding(s) in Company
3rd Jul 20253:00 pmRNSBlock listing Interim Review
3rd Jul 202512:00 pmRNSTotal Voting Rights
3rd Jul 20259:30 amRNSHolding(s) in Company
23rd Jun 20258:26 amRNSReport on Payments to Govts
20th Jun 202512:31 pmRNSDirector/PDMR Shareholding
12th Jun 20253:00 pmRNSHolding(s) in Company
12th Jun 20252:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.